新华社南昌6月23日电 题："红都"续写新传奇——解码"共和国摇篮"瑞金的文化自信样本 新华社记者沈锡权、赖星、闵尊涛 江西瑞金，被誉为"共和国的摇篮"，铭刻着中国共产党敢教日月换新天的雄心壮志。 2024年5月，江西省瑞金市城区（无人机照片）。新华社发（刘黎明 摄） 红旗漫卷处 青春再出发 "我要去瑞金，去走我哥走过的路……" 热播电视剧《追风者》男主角魏若来的深情独白，点燃了许多年轻人对瑞金的向往。 1931年11月7日，一批来自五湖四海、风华正茂的人们在此宣告中华苏维埃共和国临时中央政府成立，为这片土地注入了改写民族命运的红色基 因。 2025年5月，中华苏维埃共和国国家银行旧址前游客云集，打卡留念。（受访者供图） 习近平总书记2019年5月在江西考察时强调，革命理想高于天。理想信念之火一经点燃，就永远不会熄灭。 在新时代坐标里，瑞金既葆有鲜明的红色气质，又彰显出创新超越气魄——这座在传承中奋进、在革新中蜕变、在拼搏中突围的"红色故都"，正 以高质量发展的强劲势头，续写永不褪色的精神传奇。 相隔千里，江西瑞金和上海瑞金医院从以前的对接不多，到近年来加深合作。中国工程院院士、上海瑞金医院院长宁光注意到，现 ...

"中国已经领先一步（already has a head start）。" 在本月的一篇科技报道中，美国消费者新闻与商业频道 （CNBC）这样写道。 在这家头部美国商业媒体看来，眼下不仅是关税问题在时刻提醒美国企业自己有多么依赖中国工厂；如 今人工智能和机器人等新技术的入场，也在不断放大中国企业的优势。"随着越来越多的工厂转向人工 智能（AI）和机器人等技术来削减成本和控制质量，中国供应链正在变得更有吸引力。" "人工智能为中国供应链带来更大优势" 美国媒体报道截图 人工智能让中国制造和供应链更强大，已经成为很多人不约而同的共识。 初创公司Cybord首席执行官科恩（Oshri Cohen）表示，中国企业渴求新技术，该公司旗下基于AI开发 的质量控制工具，将在中国找到大买家。在这位曾经的英伟达供应链副总裁看来，地缘政治压力将使供 应链更加多元化，最终提升中国工厂的竞争力。"工厂将回归中国，"科恩说，"中国将成为高质量的典 范。" "当你深思数字化转型及制造业的自动化数字分析时，会发现中国企业是世界上一股真正的力量。"麦肯 锡驻深圳高级合伙人埃洛特（Karel Eloot）感叹道。埃洛特提到，自2018年世界经 ...

1)长期资金入市，权益投资有望贡献弹性。2)行业投资组合结构：债券和权益投资比例有望持续提升， 债券占比维持高位同时结构不断优化，边际来看占比增速或将放缓。长期资金入市，股票配置占比预计 将持续提升。人身险公司纯股票配置占比8.4%，同比+0.9 pct，连续三个季度保持回升;财险公司纯股票 占比7.6%，同比+0.4 pct，同样延续小幅上行趋势。3)IFRS9下的投资组合：OCI有望持续增配，以高股 息高分红标的寻找确定性。 内含价值：NBV有望持续改善，头部险企EV增长分化，聚焦资负匹配能力 伴随分红险切换和渠道"报行合一"费用管控，长期投资收益率假设调整的负面影响有望逐步消化，潜在 利差损压力有望逐步减轻，后续资产负债更为匹配、业务结构和渠道质态较好的险企有望更为受益， ROEV整体表现有望显著回暖。 风险提示：政策不及预期、资本市场波动加大、居民财富增长不及预期、长期利率下行超预期、险企改 革不及预期。 1)保费增长：新单保费预计继续承压，结构质态有望改善，NBV预计延续正增长。新单保费方面，该行 预计2025年主要上市险企整体仍将承压，除新华保险外，预计将维持负增长，总保费方面，由于有过去 续期保 ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Q3 2023 Earnings Conference Call November 9, 2023 Conference Call Participants Moderator: Taylor Devlin CytoSorbents Corporation Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer 2 Kathleen Bloch, MBA, CPA Chief Financial Officer Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Eu ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Q4 2023 and FY 2023 Earnings Conference Call March 14, 2024 Conference Call Participants Moderator: Taylor Devlin CytoSorbents Corporation Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSor ...

Core Points - FirstFarms' Board of Directors has decided to issue 42,000 warrants, allowing the subscription of shares totaling 420,000 DKK [1] - The exercise price for the warrants is set at 65.16 DKK per share, with allocations made cost-free to Co-CEOs and other managers [2] - The total market value of the issued warrants is estimated at 546,040 DKK, calculated using the Black-Scholes model [4] Summary by Sections Warrants Allocation - The Board has allocated 25,000 warrants to the two Co-CEOs and 17,000 warrants to other managers [2] - The warrants can be utilized within a 4-week period following the release of the annual report for the year 2027 [2] Conditions of Utilization - If an employee resigns as a "bad leaver," unutilized warrants will lapse immediately without compensation [3] - Employees resigning as "good leavers" will retain their rights to the allotted warrants [3] Financial Valuation - The market value of the warrants is based on a volatility of 11%, a risk-free interest rate of 2% per annum, and a share price of 75.00 DKK [4] - The estimated annual value of the warrants is 182,000 DKK until potential utilization [4] Company Overview - FirstFarms is a Danish stock exchange-listed company focused on sustainable operations and community responsibility [6]

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Nasdaq: CTSO Q1 2024 Earnings Conference Call May 9, 2024 Conference Call Participants Moderator: Eric Ribner LifeSci Advisors Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Europe GmbH Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Of ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Nasdaq: CTSO Q2 2024 Earnings Conference Call August 13, 2024 Conference Call Participants Moderator: Eric Ribner LifeSci Advisors Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Europe GmbH Christopher Cramer, MS, MBA Senior VP Business Development 2 Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Eft ...

The Emergence of CytoSorbents Corporation Nasdaq: CTSO Q3 2024 Earnings Conference Call November 7, 2024 DrugSorb-ATR is an investigational device currently under U.S. FDA and Health Canada review. It is not yet approved or cleared in any country. Conference Call Participants Moderator: Adanna Alexander, PhD ICR Healthcare Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer Christopher Cramer, MS, MBA Senior VP Business Development 2 Phillip Chan, MD, PhD Chief Executive Officer Vincen ...

东 兴 晨 报 2025 年 6 月 23 日星期一 经济要闻 1. 财政部：1—5 月证券交易印花税 668 亿元 同比增长 52.4%。财政部数 据显示，1—5 月，全国一般公共预算收入 96623 亿元，同比下降 0.3%。其中， 全国税收收入 79156 亿元，同比下降 1.6%；非税收入 17467 亿元，同比增长 6.2%。分中央和地方看，中央一般公共预算收入 41486 亿元，同比下降 3%； 地方一般公共预算本级收入 55137 亿元，同比增长 1.9%。1—5 月印花税 1787 亿元，同比增长 18.8%。其中，证券交易印花税 668 亿元，同比增长 52.4%。 （资料来源：同花顺） 2. 央行：跨境支付通支持内地与香港间人民币和港币的跨境汇款。央行有 关部门负责人就跨境支付通答记者问表示，跨境支付通是将中国内地快速支 付系统与其他货币当局的快速支付系统连接，制定配套政策安排，为中国内 地居民与境外居民间提供高效、便捷、安全的跨境支付服务。与传统跨境汇 款相比，跨境支付通有效缩短了跨境汇款链路，提高了跨境汇款效率，支持 用户通过参与机构的手机银行、网上银行等渠道，依托手机号码、银行账户 ...